An article looking at the marketing female sexual dysfunction
“The pharmaceutical industry’s dreams of making large profits from treating female sexual dysfunction are starting to look like premature speculation.”
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
How smartphones are stealing your focus—and what you can do about it
-
Internal Medicine 2025: inspiration at the annual meeting
-
The heartbreaking pandemic story I will never forget
-
How Earth Day can inspire better health for doctors and patients
-
Why female physicians are done asking for permission
-
Spreading hope one card at a time for doctors’ well-being [PODCAST]
-
Past 6 Months
-
How trade wars could destroy the U.S. health care system
-
How hospitals are quietly taking control of physicians
-
The silent crisis hurting pain patients and their doctors
-
How the system hunts physicians who refuse to kneel
-
Doctors don’t need yoga, they need time to smoke
-
What happened to real care in health care?
-
Recent Posts
-
Internal Medicine 2025: inspiration at the annual meeting
-
A surgeon’s late-night crisis reveals the cost confusion in health care
-
Why patients and doctors are ditching insurance for personalized care
-
Staying stone free with AI: How smart tech is revolutionizing kidney stone prevention
-
Overcoming the curse of knowledge: Why doctors need to translate medicine [PODCAST]
-
Signing bonuses and taxes: What physicians should know
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
